presbyopia
02.25.21
Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of PresbyopiaSource: Allergan
02.18.21
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in PresbyopiaSource: Ocuphire Pharma
12.16.20
Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for PresbyopiaSource: Eyenovia
11.12.20
Adaptilens Announces $1.6 Million in Seed Funding for Development of Accommodating IOLSource: Adaptilens
11.05.20
Staar Surgical Begins Commercialization of EVO Viva Presbyopia Correcting LensSource: Staar Surgical
10.06.20
UH Professor Developing New Technology to Detect Lens Elasticity Associated With PresbyopiaSource: University of Houston
10.02.20
Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for PresbyopiaSource: Orasis Pharmaceuticals
09.30.20
Biotech Healthcare Launches Optiflex TRIO Trifocal IOL in EuropeSource: Biotech Healthcare